Showing 1,101 - 1,120 results of 106,181 for search '(( a de decrease ) OR ( 5 ((((teer decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.40s Refine Results
  1. 1101
  2. 1102
  3. 1103
  4. 1104
  5. 1105
  6. 1106
  7. 1107
  8. 1108
  9. 1109
  10. 1110

    FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

    Published 2019
    “…<p>(A) HuH6 cells (2.5 x 10<sup>6</sup> cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”
  11. 1111
  12. 1112

    Telomestatin induces a de-localization of Topo III from TIN2 and TRF1. by Nassima Temime-Smaali (260017)

    Published 2009
    “…<p>Representative images are of untreated MRC5-V1/YFP-Topo III cells or cells treated for 48 h with 2 µM telomestatin. …”
  13. 1113
  14. 1114
  15. 1115
  16. 1116
  17. 1117
  18. 1118
  19. 1119

    Data_Sheet_1_v1_Role of Female Research at the Asociacion Mexicana de Cirugia General Annual Meeting: A Retrospective Analysis From 2013 to 2019.pdf by Lorelí Mejía-Fernández (12539746)

    Published 2022
    “…The percentage of females’ abstracts selected for oral presentation was less than the percentage of males’ 49 abstracts selected for presentation (9% vs. 11.5%; p = 0.002). Females’ abstracts submitted have a 50 23.5% decreased chance of being selected for oral presentation (OR = 0.765, CI 95%, 0.639–0.917, 51 p = 0.003). …”
  20. 1120

    Data_Sheet_1_v1_Role of Female Research at the Asociacion Mexicana de Cirugia General Annual Meeting: A Retrospective Analysis From 2013 to 2019.pdf by Lorelí Mejía-Fernández (12539746)

    Published 2022
    “…The percentage of females’ abstracts selected for oral presentation was less than the percentage of males’ 49 abstracts selected for presentation (9% vs. 11.5%; p = 0.002). Females’ abstracts submitted have a 50 23.5% decreased chance of being selected for oral presentation (OR = 0.765, CI 95%, 0.639–0.917, 51 p = 0.003). …”